Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Sep 16, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell

This study aimed to evaluate a minimally invasive surgical treatment option for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). This study found that the temporary implantable nitinol device (iTIND) is a promising technique for these patients. 

Some background

Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. BPH can impede the flow of urine. This leads to lower urinary tract symptoms (LUTS) such as dribbling of urine and a feeling of incomplete bladder emptying. This can have a poor effect on the quality of life. One surgical option is the temporary implantable nitinol device (iTIND). An earlier version of this treatment option is the TIND. This device is implanted into the urethra (the tube that urine passes through). It exerts pressure on the prostate, widening it. It is taken out after a few days. 

Its effectiveness is still under investigation.

Methods & findings

This study analyzed the results of 3 other articles about TIND and iTIND in patients with BPH-related LUTS. The functional outcomes were analyzed. 

Both the TIND and iTIND implantations were safe, effective, and well-tolerated procedures. Side-effects included blood in urine, pain and painful urination. These were usually in the short-term. The overall quality of life and symptom score improved from 3 to 12 months after the surgery and no patients required additional surgical treatments.

The bottom line

This study found that iTIND is a promising technique in patients with BPH-related LUTS. 

The fine print

This study included 3 other studies with different protocols. A large study with a long follow-up period is needed for stronger evidence.

Published By :

Current urology reports

Date :

Jul 05, 2019

Original Title :

First- and Second-Generation Temporary Implantable Nitinol Devices As Minimally Invasive Treatments for BPH-Related LUTS: Systematic Review of the Literature.

click here to get personalized updates